Login
| TI Ref No : | 525990573 |
|---|---|
| Description : | The Tender Involves The Conclusion Of A Non-exclusive Discount Agreement According To ยง 130a Paragraph 8 Sgb V For The Active Ingredient Lebrikizumab, Atc D11ah10, For The Period From January 1, 2026, To December 31, 2027. The Dak-gesundheit Intends To Co |
| Date : | 2025-12-09 |
| Deadline : | 2026-06-06 |
| Document Type : | Tenders |
